Literature DB >> 31512200

Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study.

Azraa Amroze1, Kathleen Mazor1,2, Sybil Crawford2, Kevin O'Day3, David D McManus1,2,3, Alok Kapoor4,5,6.   

Abstract

Half of patients with atrial fibrillation (AF) and elevated stroke risk do not receive anticoagulation (AC). Explanations for undertreatment may relate to provider lack of confidence with or knowledge of the CHA2DS2-VASc stroke calculator, unfamiliarity with direct oral anticoagulants (DOACs), or uncertainty about use of AC after bleeding events or other challenging patient scenarios. We surveyed cardiology and primary care providers (PCPs) within a large healthcare system to investigate prescriber knowledge, confidence, and comfort prescribing AC for AF in challenging scenarios. Of 112 providers invited, 70 (63%) completed our survey. Compared with non-responding providers, responding providers had fewer years in practice and more often worked in a university setting. Responding providers were moderately or very confident with use of CHA2DS2-VASc calculator (90%). Cardiology providers reported substantial knowledge about DOACs (72%) compared with PCPs (33%). Both provider groups reported reluctance prescribing AC when presented with challenging patient scenarios (% providers agreeing with AC): three falls over 6 months (36%), 2 weeks after resolved gastrointestinal bleed (21%), 4 weeks after intracranial bleeding (9%), in a patient consuming five alcoholic drinks per day (44%). All providers were moderately or very confident with using the CHA2DS2-VASc calculator, but only cardiology providers reported substantial knowledge about DOACs. Our providers were reluctant to prescribe AC after bleeding and in other common situations where use of AC may be appropriate. Education of PCPs about DOACs and development of guidelines to address challenging patient scenarios may improve AC prescription rates in patients with AF.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Physician practice patterns; Risk and benefit

Mesh:

Substances:

Year:  2019        PMID: 31512200     DOI: 10.1007/s11239-019-01950-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  17 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  The impact of CME on physician performance and patient health outcomes: an updated synthesis of systematic reviews.

Authors:  Ronald M Cervero; Julie K Gaines
Journal:  J Contin Educ Health Prof       Date:  2015       Impact factor: 1.355

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

Authors:  M Man-Son-Hing; G Nichol; A Lau; A Laupacis
Journal:  Arch Intern Med       Date:  1999-04-12

Review 5.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Authors:  Isla M Ogilvie; Nick Newton; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Journal:  Am J Med       Date:  2010-07       Impact factor: 4.965

Review 6.  What to do after the bleed: resuming anticoagulation after major bleeding.

Authors:  Daniel M Witt
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

7.  Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for adult patients with atrial fibrillation.

Authors:  Scott A Chapman; Catherine A St Hill; Meg M Little; Michael T Swanoski; Shellina R Scheiner; Kenric B Ware; M Nawal Lutfiyya
Journal:  BMC Health Serv Res       Date:  2017-02-11       Impact factor: 2.655

Review 8.  Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

Authors:  Candice L Garwood; Tia L Corbett
Journal:  Ann Pharmacother       Date:  2008-03-11       Impact factor: 3.154

9.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

Authors:  D C McCrory; D B Matchar; G Samsa; L L Sanders; E L Pritchett
Journal:  Arch Intern Med       Date:  1995-02-13

10.  Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.

Authors:  David J Gladstone; Esther Bui; Jiming Fang; Andreas Laupacis; M Patrice Lindsay; Jack V Tu; Frank L Silver; Moira K Kapral
Journal:  Stroke       Date:  2008-08-28       Impact factor: 7.914

View more
  2 in total

1.  Prescribing of anticoagulation for atrial fibrillation in primary care.

Authors:  Kathryn A Martinez; Mark H Eckman; Matthew A Pappas; Michael B Rothberg
Journal:  J Thromb Thrombolysis       Date:  2022-04-21       Impact factor: 2.300

2.  GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study.

Authors:  Jong-Wook Ban; Rafael Perera; Richard Stevens
Journal:  BJGP Open       Date:  2020-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.